No Data
No Data
No Data
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer's
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024